A Study of Azithromycin in the Prevention of Mycobacterium Avium Complex Disease (MAC) in HIV-Infected Patients

NCT00002309 · clinicaltrials.gov ↗

NA

Phase

COMPLETED

Status

INDUSTRY

Sponsor class

Conditions

Mycobacterium Avium-Intracellulare Infection
HIV Infections

Interventions

DRUG: Azithromycin

Sponsor

Pfizer